Results 201 to 210 of about 28,020 (301)

A nationwide 12‐month observatory of automated insulin delivery shows improved glucose control, sustained adoption, and reduced acute severe events

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims A nationwide observational study was conducted to assess the 12‐month effectiveness of AID systems in the routine care of people with Type 1 diabetes (PwT1D). Methods All PwT1D, adults, and children, who initiated AID between January 1, 2022, and December 31, 2022, were included across 79 centres.
Jean‐Pierre Riveline, Jean‐Baptiste Julla, Elisabeth Bonnemaison, Michael Joubert, Sandrine Lablanche, Agnès Sola Gazagnes, Delphine Demarsy, Didier Gouet, Pauline Schaepelynck, Chloé Amouyal, Fabienne Dalla Vale, Anne Schletzer‐Mari, Sylvaine Clavel, Anne Spiteri, Catherine Campinos, Sandrine Favre, Igor Tauveron, Laurence Mathivon, Sophie Borot, Guy Fagherazzi, Marc D. Breton, Jean‐François Gautier, Eric Renard, for the OB2F study group, Jean‐Pierre Riveline, Manal Al Masri‐Shbat, Emmanuel Cosson, Isabela Banu, Michael Joubert, Agnès Sola Gazagnes, Gaetan Prevost, Sandrine Lablanche, Pauline Schaepelynck, Charles Thivolet, Nicolas Chevalier, Sophie Borot, Bruno Guerci, Elise Bismuth, Jacques Beltrand, Delphine Demarsy, Emmanuelle Bourrinet, Didier Gouet, Lucien Marchand, Louis Gerbaud‐Morlaes, Salha Fendri, Sylvaine Clavel, René Valero, Emmanuel Sonnet, Blandine Delenne, Jean‐Paul Donnet, Emma Carreira, Cedric Fagour, Camille Vatier, Rosine Guintrand, Luc Rakotoarisoa, Aurélie Carlier, Anne Spiteri, Igor Tauveron, Lemoine Amal, Letitia Pantalone, Anne Schletzer, Karen Berthelon, Natacha Germain, Françoise Latil Plat, Aroua Temessek, Marie Mansilla, Lorraine Thomesse, Fabienne Dalla Valle, Anne‐Cécile Paepegaey, Nadège Bachere, Candace Ben Signor, Samy Hadjadj, Thanh Lan Dangduy, Mathieu Giraud, Sandrine Favre, Joëlle Dupont, Anna Flaus Furmaniuk, Laure Houdon Nguyen, Patricia Pigeon Kherkiche, Anne‐Cécile Gauthier, Anne Vambergue, Alina Radu, Sandra Pochelu, Abine Baron, Chloé Amouyal, Jennifer Allain‐Cohen, Mariana Geamanu, Florent Verdier, Yannis Chartier, Nathalie Garrec, Annie Sfez, laurence Mathivon, Christine Rouby, Emeline Renard, Agnès Tamboura, Leïla Mchirgui, PH Emilie Georget, Elise Pinto da Rocha, Laure Oilleau‐Barral   +98 more
wiley   +1 more source

External Neurolysis and Hypothenar Fat Pad Flap With Early Nerve Gliding Exercise Regimen for Recurrent Carpal Tunnel Syndrome. [PDF]

Cureus
Maxwell AJ, Risser I, Arefi IA, Bahar Moni AS.   +3 more
europepmc   +1 more source

Efficacy and safety of bi‐weekly cofrogliptin treatment replacing daily dipeptidyl peptidase‐4 inhibitors in Chinese patients with type 2 diabetes mellitus: A multicenter, open‐label, randomized controlled phase 2 trial

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aim This study aimed to investigate the efficacy and safety of bi‐weekly cofrogliptin treatment as a replacement for daily dipeptidyl peptidase‐4 inhibitors (DPP‐4is) in Chinese patients with type 2 diabetes mellitus (T2DM). Methods This multicenter, open‐label, randomized controlled study assigned participants in a 1:1 ratio to either the ...
Congqing Pan, Hongwei Jiang, Yi Feng, Suijun Wang, Jin Zhang, Zhongjing Wang, Yusen Zhou, Fangqiong Li, Zhanhui Zhang, Yaming Li, Liming Chen   +10 more
wiley   +1 more source

Pathophysiology of Wound Development and Chronicity in Renal Disease: A Narrative Review. [PDF]

Int Wound J
Sandepudi K, Shah KV, Melnick BA, Li RA, Ho K, O'Connor MJ, Galiano RD.   +6 more
europepmc   +1 more source

Effects of vibration therapy on clinical manifestations of Diabetic Peripheral Neuropathy: A Systematic Review

dos Santos Soares, Francyelle, Yoshida, Letícia Natsumi, Coldebella, Anna Karoline   +2 more
openalex   +1 more source

Severity of complications is associated with impaired health‐related quality of life in people with type 1 diabetes

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Health‐related quality of life (HRQoL) assessment is increasingly integrated into type 1 diabetes (T1D) monitoring to promote a holistic approach. To investigate HRQoL in adults with T1D and to assess the impact of the severity of complications on HRQoL.
Sara Barraud, Gloria A. Aguayo, Emmanuel Cosson, Chloé Amouyal, Sylvie Feldman, Jean‐François Gautier, Patricia Vaduva, Samy Hadjadj, Hélène Hanaire, Laurence Kessler, Emmanuelle Lecornet‐Sokol, Pascale Massin, Louis Potier, Eric Renard, Yves Reznik, Agnès Sola, Anne Vambergue, Camille Vatier, Bruno Vergès, Jean‐Pierre Riveline, Guy Fagherazzi   +20 more
wiley   +1 more source

Screening and monitoring of diabetic polyneuropathy in clinical practice: present and future with connected devices. [PDF]

Front Neurol
Lefaucheur JP.
europepmc   +1 more source

Sensory network dysregulation in type 2 diabetes: Linking olfactory, visual, and cognitive function

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims This study investigates the relationship between multisensory (visual, somatosensory, and olfactory) dysfunction and cognitive decline in Type 2 diabetes (T2D), with a particular focus on the mediating role of olfactory dysfunction. Methods We used resting‐state fMRI to assess seed‐based functional connectivity from the primary sensory ...
Qian Li, Xin Li, Yan Bi, Jiaming Lu, Yi Zhang, Min Wu, Xinyi Shen, Zhengyang Zhu, Xin Zhang, Yining Chao, Zhou Zhang, Wen Zhang, Bing Zhang   +12 more
wiley   +1 more source

Artificial Intelligence in Neuro-Ophthalmology: Opportunities for the Diagnosis of Optic Neuropathies and Visual Pathway Disorders. [PDF]

Cureus
Karkhur S, Beri A, Verma V, Gupta S, Singh P.   +4 more
europepmc   +1 more source

PIONEER REAL Saudi Arabia: A multicentre, prospective, real‐world study of once‐daily oral semaglutide use in adults with type 2 diabetes in Saudi Arabia

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aim PIONEER REAL Saudi Arabia investigated real‐world clinical outcomes associated with the use of once‐daily oral semaglutide in adults with type 2 diabetes (T2D). Materials and Methods This was a 34‐ to 44‐week multicentre, prospective, open‐label study in adults with T2D, who were treatment‐naive to injectable glucose‐lowering medication ...
Hussein ElBadawi, Nader Albalkhi, Ibrahim Al Kadhim, Ahmed Elsadig, Dimitrios Baltzis, Mohamed Hassan Hatahet, Mahmoud Ismail, Said Khader, Christina Louise Rasmussen, Stine Hedegaard Scheuer, Ahmed Shalaby, Mohammed Almehthel   +11 more
wiley   +1 more source